Global Health Commodities Supply Chain in the Era of COVID-19 Pandemic: Challenges, Impacts, and Prospects: A Systematic Review

References

• Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. 2020;55(5):105951. doi:10.1016/j.ijantimicag.2020.105951
   PubMed Web of Science ®Google Scholar
• World Health Organization. Wuhan 2019 Novel Coronavirus - 2019-nCoV Situation Report 11 - 31th January 2020. WHO Bull. 2020;10:1.
   Google Scholar
• Yu DEC, Razon LF, Tan RR. Can global pharmaceutical supply chains scale up sustainably for the COVID-19 crisis? Resour Conserv Recycl. 2020;159:104868. doi:10.1016/j.resconrec.2020.104868
   PubMed Web of Science ®Google Scholar
• Nikolopoulos K, Punia S, Schäfers A, Tsinopoulos C, Vasilakis C. Forecasting and planning during a pandemic: COVID-19 growth rates, supply chain disruptions, and governmental decisions. Eur J Oper Res. 2020. doi:10.1016/j.ejor.2020.08.001
   Web of Science ®Google Scholar
• Wouters OJ, Shadlen KC, Salcher-Konrad M, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397(10278):1023–1034. doi:10.1016/S0140-6736(21)00306-8
   PubMed Web of Science ®Google Scholar
• Chang J, Agliata J, Guarinieri M. COVID-19 - Enacting a ‘new normal’ for people who use drugs. Int J Drug Policy. 2020;83(xxxx):102832. doi:10.1016/j.drugpo.2020.102832
   PubMedGoogle Scholar
• Ivanov D. Predicting the impacts of epidemic outbreaks on global supply chains: a simulation-based analysis on the coronavirus outbreak (COVID-19/SARS-CoV-2) case. Transp Res Part E Logist Transp Rev. 2020;136:101922. doi:10.1016/j.tre.2020.101922
   PubMed Web of Science ®Google Scholar
• Rewari BB, Mangadan-Konath N, Sharma M. Impact of COVID-19 on the global supply chain of antiretroviral drugs: a rapid survey of Indian manufacturers. WHO South-East Asia J. 2020;9(2):126–133. doi:10.4103/2224-3151.294306
   Google Scholar
• Badreldin HA, Atallah B. Global drug shortages due to COVID-19: impact on patient care and mitigation strategies. Res Soc Adm Pharm. 2020;0–1. doi:10.1016/j.sapharm.2020.05.017
   Web of Science ®Google Scholar
• Walker PGT, Whittaker C, Watson OJ, et al. The impact of COVID-19 and strategies for mitigation and suppression in low- And middle-income countries. Science. 2020;369(6502):413–422. doi:10.1126/science.abc0035
   PubMed Web of Science ®Google Scholar
• Gereffi G. What does the COVID-19 pandemic teach us about global value chains? The case of medical supplies. J Int Bus Policy. 2020;3(3):287–301. doi:10.1057/s42214-020-00062-w
   Google Scholar
• Kuo S, Ou HT, Wang CJ. Managing medication supply chains: lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future. J Am Pharm Assoc. 2020. doi:10.1016/j.japh.2020.08.029
   Google Scholar
• Hogan AB, Jewell BL, Sherrard-Smith E, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Heal. 2020;8(9):e1132–e1141. doi:10.1016/S2214-109X(20)30288-6
   PubMed Web of Science ®Google Scholar
• Newton PN, Bond KC, Adeyeye M, et al. COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. Lancet Glob Heal. 2020;8(6):e754–e755. doi:10.1016/S2214-109X(20)30136-4
   PubMed Web of Science ®Google Scholar
• Singh TU, Parida S, Lingaraju MC, Kesavan M, Kumar D, Singh RK. Drug repurposing approach to fight COVID-19. Pharmacol Rep. 2020;72(0123456789):1479–1508. doi:10.1007/s43440-020-00155-6
   PubMedGoogle Scholar
• Hassan SA, Sheikh FN, Jamal S, Ezeh JK, Akhtar A. Coronavirus (COVID-19): a review of clinical features, diagnosis, and treatment. Cureus. 2020. doi:10.7759/cureus.7355
   Google Scholar
• Shrotri M, Swinnen T, Kampmann B, Parker EPK. An interactive website tracking COVID-19 vaccine development. Lancet Glob Heal. 2021;9(5):e590–e592. doi:10.1016/S2214-109X(21)00043-7
   PubMed Web of Science ®Google Scholar
• Randolph HE, Barreiro LB. Herd Immunity: understanding COVID-19. Immunity. 2020;52(5):737–741. doi:10.1016/j.immuni.2020.04.012
   PubMed Web of Science ®Google Scholar
• Park H, Kim SH. A study on herd immunity of COVID-19 in South Korea: using a stochastic economic-epidemiological model. Environ Resour Econ. 2020;76(4):665–670. doi:10.1007/s10640-020-00439-8
   PubMed Web of Science ®Google Scholar
• Sinha P, Kumar S, Chandra C. Strategies for ensuring required service level for COVID-19 herd immunity in Indian vaccine supply chain. Eur J Oper Res. 2021. doi:10.1016/j.ejor.2021.03.030
   Web of Science ®Google Scholar
• Karmaker CL, Ahmed T, Ahmed S, Ali SM, Moktadir MA, Kabir G. Improving supply chain sustainability in the context of COVID-19 pandemic in an emerging economy: exploring drivers using an integrated model. Sustain Prod Consum. 2020. doi:10.1016/j.spc.2020.09.019
   PubMed Web of Science ®Google Scholar
• Weiss DJ, Bertozzi-Villa A, Rumisha SF, et al. Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis. Lancet Infect Dis. 2020;3099(20):1–11. doi:10.1016/s1473-3099(20)30700-3
   Google Scholar
• Awucha NE, Janefrances OC, Meshach AC, Henrietta JC, Daniel AI, Chidiebere NE. Impact of the COVID-19 Pandemic on Consumers. Acc Ess Med Nig. 2020;103(4):1630–1634. doi:10.4269/ajtmh.20-0838
   Google Scholar
• Kargar S, Pourmehdi M, Paydar MM. Science of the Total Environment Reverse logistics network design for medical waste management in the epidemic outbreak of the novel coronavirus (COVID-19). Sci Total Environ. 2020;746:141183. doi:10.1016/j.scitotenv.2020.141183
   PubMed Web of Science ®Google Scholar
• Onchonga D, Omwoyo J, Nyamamba D. Assessing the prevalence of self-medication among healthcare workers before and during the 2019 SARS-CoV-2 (COVID-19) pandemic in Kenya. Saudi Pharm J. 2020;2(xxxx). doi:10.1016/j.jsps.2020.08.003
   Google Scholar
• Downs CG, Varisco TJ, Bapat SS, Shen C, Thornton JD. Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications. Res Soc Adm Pharm. 2020;10–13. doi:10.1016/j.sapharm.2020.06.003
   Web of Science ®Google Scholar
• Jewell BL, Mudimu E, Stover J, et al. Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models. Lancet HIV. 2020;7(9):e629–e640. doi:10.1016/S2352-3018(20)30211-3
   PubMed Web of Science ®Google Scholar
• Jewell BL, Smith JA, Hallett TB. Understanding the impact of interruptions to HIV services during the COVID-19 pandemic: a modelling study. EClinicalMedicine. 2020;26:100483. doi:10.1016/j.eclinm.2020.100483
   PubMedGoogle Scholar
• Rebmann T, Vassallo A, Holdsworth JE. Availability of personal protective equipment and infection prevention supplies during the first month of the COVID-19 pandemic: a national study by the APIC COVID-19 task force. Am J Infect Control. 2020. doi:10.1016/j.ajic.2020.08.029
   Web of Science ®Google Scholar
• Alam ST, Ahmed S, Ali SM, Sarker S, Kabir G, ul-Islam A. Challenges to COVID-19 vaccine supply chain: implications for sustainable development goals. Int J Prod Econ. 2021;239(April):108193. doi:10.1016/j.ijpe.2021.108193
   PubMedGoogle Scholar
• Gaudette É. COVID-19’s limited impact on drug shortages in Canada. Can Public Policy. 2020;46(3):S307–S312. doi:10.3138/CPP.2020-107
   Google Scholar
• Aljadeed R, AlRuthia Y, Balkhi B, et al. The impact of covid-19 on essential medicines and personal protective equipment availability and prices in Saudi Arabia. Healthc. 2021;9(3):290. doi:10.3390/healthcare9030290
   Google Scholar
• Kumar A, Luthra S, Mangla SK, Kazançoğlu Y. COVID-19 impact on sustainable production and operations management. Sustain Oper Comput. 2020;1:1–7. doi:10.1016/j.susoc.2020.06.001
   Google Scholar
• Socal MP, Sharfstein JM, Greene JA. Critical drugs for critical care: protecting the US pharmaceutical supply in a time of crisis. Am J Public Health. 2020;110(9):1346–1347. doi:10.2105/AJPH.2020.305803
   PubMed Web of Science ®Google Scholar
• Sharma A, Gupta P, Jha R. COVID-19: impact on health supply Chain and lessons to be learnt. J Health Manag. 2020;22(2):248–261. doi:10.1177/0972063420935653
   Web of Science ®Google Scholar
• Sharma A, Adhikary A, Borah SB. Covid-19′s impact on supply chain decisions: strategic insights from NASDAQ 100 firms using Twitter data. J Bus Res. 2020;117:443–449. doi:10.1016/j.jbusres.2020.05.035
   PubMed Web of Science ®Google Scholar
• Fei H, Yinyin X, Hui C, et al. The impact of the COVID-19 epidemic on tuberculosis control in China. Lancet Reg Heal. 2020;3:100032. doi:10.1016/j.lanwpc.2020.100032
   Google Scholar
• Nieuwlaat R, Mbuagbaw L, Mertz D, et al. Coronavirus disease 2019 and antimicrobial resistance: parallel and interacting health emergencies. Clin Infect Dis. 2020;2:2019–2021. doi:10.1093/cid/ciaa773
   Google Scholar
• Kaye AD, Okeagu CN, Pham AD, et al. Economic impact of COVID-19 pandemic on healthcare facilities and systems: international perspectives. Best Pract Res Clin Anaesthesiol. 2020. doi:10.1016/j.bpa.2020.11.009
   Web of Science ®Google Scholar
• Golan MS, Jernegan LH, Linkov I. Trends and applications of resilience analytics in supply chain modeling: systematic literature review in the context of the COVID ‑ 19 pandemic. Environ Syst Decis. 2020;40(2):222–243. doi:10.1007/s10669-020-09777-w
   PubMedGoogle Scholar